Illumina (ILMN) Q2 2012 Earnings Call July 24, 2012 5:00 pm ET Executives Kevin Williams Marc Stapley - Chief Financial Officer, Senior Vice President and Principal Accounting Officer Jason T. Flatley - Chief Executive Officer, President and Director Christian O. Henry - Senior Vice President and General Manager of Genomic Solutions Analysts Tycho W. Peterson - JP Morgan Chase & Co, Research Division Doug Schenkel - Cowen and Company, LLC, Research Division Amanda Murphy - William Blair & Company L.L.C., Research Division Derik De Bruin - BofA Merrill Lynch, Research Division Ross Muken - ISI Group Inc., Research Division William R. Quirk - Piper Jaffray Companies, Research Division Daniel Brennan - Morgan Stanley, Research Division Nandita Koshal - Barclays Capital, Research Division Isaac Ro - Goldman Sachs Group Inc., Research Division Daniel L. Leonard - Leerink Swann LLC, Research Division Daniel Arias - UBS Investment Bank, Research Division Peter Lawson - Mizuho Securities USA Inc., Research Division Adam Darity Zarak Khurshid - Wedbush Securities Inc., Research Division Paul R. Knight - Credit Agricole Securities (USA) Inc., Research Division PresentationOperator
Good day, ladies and gentlemen, and welcome to the Second Quarter 2012 Illumina Incorporated Earnings Conference Call. My name is Melanie, and I'll be your coordinator today. [Operator Instructions] As a reminder, today's call will be recorded. I would now like to turn the call over to Mr. Kevin Williams. Please proceed. Kevin Williams Thank you. Good afternoon, everyone, and welcome to our earnings call for the second quarter of 2012. During the call, we will review our financial results released today after the close of the market and offer commentary on our commercial activity. After which, we will host a question-and-answer session. If you have not had a chance to review the earnings release, it can be found in the Investor Relations section of our website at illumina.com.